174 related articles for article (PubMed ID: 24078915)
41. Common Fluorescence In Situ Hybridization Applications in Cytology.
Savic S; Bubendorf L
Arch Pathol Lab Med; 2016 Dec; 140(12):1323-1330. PubMed ID: 27479335
[TBL] [Abstract][Full Text] [Related]
42. The pathway to clinical use of a cancer biomarker.
Henry NL
Scand J Clin Lab Invest Suppl; 2016; 245():S17-21. PubMed ID: 27410238
[TBL] [Abstract][Full Text] [Related]
43. Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases.
Kessler HH; Raggam RB
Clin Chem Lab Med; 2012 Feb; 50(7):1153-9. PubMed ID: 22850049
[TBL] [Abstract][Full Text] [Related]
44. Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients.
Holdenrieder S
Adv Exp Med Biol; 2016; 924():53-60. PubMed ID: 27753019
[TBL] [Abstract][Full Text] [Related]
45. Challenges for the implementation of routine molecular diagnostics in cancer care.
de Castro DG
Expert Rev Mol Diagn; 2011 Jul; 11(6):549-51. PubMed ID: 21745007
[No Abstract] [Full Text] [Related]
46. Metagenomics for Clinical Infectious Disease Diagnostics Steps Closer to Reality.
Dekker JP
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976592
[TBL] [Abstract][Full Text] [Related]
47. Point-of-Care Testing for Infectious Diseases: Past, Present, and Future.
Kozel TR; Burnham-Marusich AR
J Clin Microbiol; 2017 Aug; 55(8):2313-2320. PubMed ID: 28539345
[TBL] [Abstract][Full Text] [Related]
48. A clinical role for Förster resonance energy transfer in molecular diagnostics of disease.
Qiu X; Hildebrandt N
Expert Rev Mol Diagn; 2019 Sep; 19(9):767-771. PubMed ID: 31353969
[No Abstract] [Full Text] [Related]
49. Cancer diagnostics: The journey from histomorphology to molecular profiling.
Ahmed AA; Abedalthagafi M
Oncotarget; 2016 Sep; 7(36):58696-58708. PubMed ID: 27509178
[TBL] [Abstract][Full Text] [Related]
50. Development of rapid, automated diagnostics for infectious disease: advances and challenges.
Ince J; McNally A
Expert Rev Med Devices; 2009 Nov; 6(6):641-51. PubMed ID: 19911875
[TBL] [Abstract][Full Text] [Related]
51. Recent advances in biomarkers for cancer diagnosis and treatment.
Manne U; Srivastava RG; Srivastava S
Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
[TBL] [Abstract][Full Text] [Related]
52. Molecular diagnostics in infectious diseases and public health microbiology: cottage industry to postgenomics.
Gilbert GL
Trends Mol Med; 2002 Jun; 8(6):280-7. PubMed ID: 12067614
[TBL] [Abstract][Full Text] [Related]
53. Emerging technologies in point-of-care molecular diagnostics for resource-limited settings.
Peeling RW; McNerney R
Expert Rev Mol Diagn; 2014 Jun; 14(5):525-34. PubMed ID: 24784765
[TBL] [Abstract][Full Text] [Related]
54. Cancer Proteomics and the Elusive Diagnostic Biomarkers.
Bradshaw RA; Hondermarck H; Rodriguez H
Proteomics; 2019 Nov; 19(21-22):e1800445. PubMed ID: 31172665
[TBL] [Abstract][Full Text] [Related]
55. Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).
Samsom KG; Bosch LJW; Schipper LJ; Roepman P; de Bruijn E; Hoes LR; Riethorst I; Schoenmaker L; van der Kolk LE; Retèl VP; Frederix GWJ; Buffart TE; van der Hoeven JJM; Voest EE; Cuppen E; Monkhorst K; Meijer GA
BMC Med Genomics; 2020 Nov; 13(1):169. PubMed ID: 33167975
[TBL] [Abstract][Full Text] [Related]
56. Application of droplet digital PCR to detect the pathogens of infectious diseases.
Li H; Bai R; Zhao Z; Tao L; Ma M; Ji Z; Jian M; Ding Z; Dai X; Bao F; Liu A
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341241
[TBL] [Abstract][Full Text] [Related]
57. Microbiological applications of high-resolution melting analysis.
Tong SY; Giffard PM
J Clin Microbiol; 2012 Nov; 50(11):3418-21. PubMed ID: 22875887
[TBL] [Abstract][Full Text] [Related]
58. Predicting cancer: can we? Should we?
Coburn C
Lancet Oncol; 2016 Nov; 17(11):1494. PubMed ID: 27819231
[No Abstract] [Full Text] [Related]
59. DNA microarrays in the clinic: infectious diseases.
Mikhailovich V; Gryadunov D; Kolchinsky A; Makarov AA; Zasedatelev A
Bioessays; 2008 Jul; 30(7):673-82. PubMed ID: 18536036
[TBL] [Abstract][Full Text] [Related]
60. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
Nara N
Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
